Discovery of an ectopic activation site on the M1 muscarinic receptor

Molecular Pharmacology

Volumn 61, Issue 6, 2002, Pages 1297-1302

  Spalding, Tracy A ^a   Trotter, Carol ^a   Skjærbæk, Niels ^a   Messier, Terri L ^a   Currier, Erika A ^a   Burstein, Ethan S ^a   Li, Donghui ^a   Hacksell, Uli ^a   Brann, Mark R ^a,b  

^a ACADIA PHARMACEUTICALS INC   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 [3 (3 METHOXYPHENYL) 2 PROPYNYLOXYIMINO] 1 AZABICYCLO[2.2.1]HEPTANE; 4 N BUTYL 1 [4 (2 METHYLPHENYL) 4 OXO 1 BUTYL]PIPERIDINE; [4 [(3 CHLOROPHENYL)CARBAMOYLOXY] 2 BUTYNYL]TRIMETHYLAMMONIUM; AC 42; ATROPINE; CARBACHOL; CHIMERIC PROTEIN; FORSKOLIN; HORMONE; ISOBUTYLMETHYLXANTHINE; MUSCARINIC M1 RECEPTOR; MUSCARINIC M1 RECEPTOR AGONIST; NEUROTRANSMITTER; OXOTREMORINE M; PILOCARPINE; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG; WAY 132983 A5; XANOMELINE;

ANIMAL CELL; ARTICLE; BINDING SITE; CONTROLLED STUDY; DRUG SELECTIVITY; EMBRYO; GENETIC CONSERVATION; HUMAN; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STRUCTURE;

3T3 CELLS; ACETYLCHOLINE; ANIMALS; BINDING SITES; HUMANS; MICE; MODELS, MOLECULAR; MUSCARINIC AGONISTS; PIPERIDINES; RADIOLIGAND ASSAY; RECEPTOR, MUSCARINIC M1; RECEPTORS, MUSCARINIC;

EID: 0036259109     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.61.6.1297     Document Type: Article

References (34)

1. Scanning mutagenesis identifies amino acid side chains in transmembrane domain 5 of the M(1) muscarinic receptor that participate in binding the acetyl methyl group of acetylcholine
2. An alpha-carbon template for the transmembrane helices in the rhodopsin family of G-protein-coupled receptors
3. 1 preferring agonist
4. Effects of xanomeline, a selective muscarinic receptor agonist, on cognitive function and behavioral symptoms in Alzheimer disease
5. Identification of a family of muscarinic acetylcholine receptor genes
6. Cloning and expression of the human and rat m5 muscarinic acetylcholine receptor genes
7. Pharmacology of muscarinic acetylcholine receptor subtypes (m1-m5): High throughput assays in mammalian cells
8. Antagonist binding properties of five cloned muscarinic receptors expressed in CHO-K1 cells
9. Interactions of muscarinic receptors with the heterotrimeric G proteins Gq and G12: Transduction of proliferative signals
10. Functional expression and properties of the human skeletal muscle sodium channel
11. The inhibitory effect of gallamine on muscarinic receptors
12. Interactions of alcuronium, TMB-8, and other allosteric ligands with muscarinic acetylcholine receptors: Studies with chimeric receptors
13. Uncovering molecular mechanisms involved in activation of G-protein coupled receptors
14. Activation of muscarinic acetylcholine receptors via their allosteric binding sites
15. Functional importance of the Ala(116)-Pro(136) region in the calcium-sensing receptor. Constitutive activity and inverse agonism in a family C G-protein-coupled receptor
16. Allosteric interactions of staurosporine and other indolocarbazoles with N-[methyl-(3)H]scopolamine and acetyl-choline at muscarinic receptor subtypes: Identification of a second allosteric site
17. Allosteric antagonists of the muscarinic acetyl-choline receptor
18. Transmembrane domains 4 and 7 of the M1 muscarinic acetylcholine receptor are critical for ligand binding and the receptor activation switch
19. Probing of the location of the allosteric site on ml muscarinic receptors by site-directed mutagenesis
20. The functional role of the binding site aspartate in muscarinic acetylcholine receptors, probed by site-directed mutagenesis
21. Crystal structure of rhodopsin: A G protein-coupled receptor
22. Novel functional M1 selective muscarinic agonists. Synthesis and structure-activity relationships of 3-(1,2,5-thiadiazolyl)-1,2,5,6-tetrahydro-l-methylpyridines
23. Constitutively active muscarinic receptors
24. Identification of a ligand-dependent switch within a muscarinic receptor
25. Acetylcholine mustard labels the binding site aspartate in muscarinic acetylcholine receptors
26. Identification of two serine residues involved in agonist activation of the beta-adrenergic receptor
27. Allele-specific activation of genetically engineered receptors
28. Design and synthesis of m1-selective muscarinic agonists: (R)-(-)-(Z)-l-azabicyclo[2.2.1]heptan-3-one, O-(3-(3′-methoxyphenyl)-2-propynyl)oxime maleate (CI-1017), a functionally m1-selective muscarinic agonist
29. Lu 25-109 a muscarinic agonist, fails to improve cognition in Alzheimer's disease
30. Alanine-scanning mutagenesis of transmembrane domain 6 of the M(1) muscarinic acetylcholine receptor suggests that Tyr381 plays key roles in receptor function
31. Site-directed mutagenesis of the m3 muscarinic receptor: Identification of a series of threonine and tyrosine residues involved in agonist but not antagonist binding
32. The M1 muscarinic agonist CI-1017 facilitates trace eyeblink conditioning in aging rabbits and increases the excitability of CA1 pyramidal neurons
33. Pharmacodynamic profile of the M1 agonist talsaclidine in animals and man
34. Functional comparison of muscarinic partial agonists at muscarinic receptor subtypes hM1, hM2, hM3, hM4 and hM5 using microphysiometry